First-in-Human Study to Evaluate Safety and Tolerability of Single and Multiple Ascending Doses of Janus Kinase-1 Inhibitor PF-04965842 in Healthy Western and Japanese Subjects
Clinical trial NCT01835197 · COMPLETED
Trial details
- NCT number
- NCT01835197
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2014-06-01
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.